Previous 10 | Next 10 |
Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital PR Newswire DALLAS , Jan. 5, 2022 /PRNewswire/ --SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the Company's board...
Enteris BioPharma Highlights 2021 Achievements and 2022 Outlook Enteris continues to capitalize on multiple value building opportunities involving Peptelligence® and ProPerma® platforms -- Received two milestone payments totaling $15 million from Cara Therapeutics ...
Biotricity (BTCY +7.3%) is trading higher after the company announced the completion of a $12M non-convertible debt financing provided by SWK Funding LLC (NASDAQ:SWKH). Per the contractual terms, the health tech company will have an initial interest-only period of two years extendable to thre...
Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022" PR Newswire BOONTON, N.J. , Dec. 20, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug produc...
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics Fourth milestone payment triggered by successful completion of process technology transfer related to the development of Oral KORSUVA™ PR Newswire D...
On November 23, 2021, SWK Holdings Corporation (NASDAQ:SWKH) says it received a non-binding proposal from Carlson Capital, L.P. to acquire all shares of SWK not already owned by Carlson for a price of $19.00 per share, payable in cash. The offer price represents an ~4.7% premium over SWK...
Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development Paper Discusses the 505(b)(2) Pathway as a Vehicle for Innovation and Product Differentiation PR Newswire BOONTON, N.J. , Nov. 17, 2021...
SWK Holdings Inc. (SWKH) Q3 2021 Results Conference Call November 15, 2021 10:00 AM ET Company Participants Winston Black - Chairman, CEO Jason Rando - Tiberend Strategic Advisors Conference Call Participants Kyle Bauser - Colliers Securities Michael Diana - Maxim group Presentation Operator ...
SWK Holdings (NASDAQ:SWKH): Q3 GAAP EPS of $0.17 misses by $0.24. Revenue of $9.56M (-10.2% Y/Y) beats by $0.91M. Press Release For further details see: SWK Holdings EPS misses by $0.24, beats on revenue
SWK Holdings Corporation Announces Financial Results for Third Quarter 2021 Conference Call and Live Audio Webcast Scheduled for Monday, November 15, 2021 at 10:00 a.m. ET PR Newswire DALLAS , Nov. 12, 2021 /PRNewswire/ -- Corporate Updates ...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...